Last updated: March 3, 2026
What is the scope of JP4955543?
JP4955543 is a pharmaceutical patent granted in Japan, related to a specific chemical compound or formulation used for treating a designated condition. While the patent document specifics are essential for detailed claims interpretation, key aspects of the scope include:
- Subject Matter: The patent claims cover a chemical entity with a particular structure, potentially a novel compound or a specific pharmaceutical formulation.
- Claims Type: The scope includes both composition claims (pharmaceutical formulations) and method claims (methods of treatment or manufacturing).
- Protection Duration: The patent was filed and granted within the standard Japanese patent term, with expiration expected around 20 years from the earliest filing date, unless extended or adjusted.
The core claims typically encompass:
- The chemical structure of a molecule with specified substituents.
- Specific dosage forms, such as tablets, capsules, or injectables.
- Methods of using the compound for treating certain diseases, possibly specified as indications.
How broad is the patent's claim coverage?
The breadth depends on claim dependency and specific language. Usually, Japanese patents in this domain feature:
- Independent claims: Cover the core chemical compound, with broad language to encompass derivatives or analogs.
- Dependent claims: Narrow scope to particular derivatives, formulations, or usage methods, providing fallback positions.
Key points:
- The compound’s claims likely specify the molecular structure with certain functional groups.
- Claims may include both the compound itself and specific applications.
- The scope may be limited to the Japanese jurisdiction with no explicit international claims unless explicitly designated.
What is the patent landscape surrounding JP4955543?
Patent landscape overview:
- Prior Art: The patent's priority date and filing date suggest it may have overlapping art with earlier chemical or pharmaceutical patents.
- Related Patents: Similar patents from competitors or research entities may exist, especially if the compound targets a common disease indication.
- Patent Family: JP4955543 is typically part of a broader family, including applications in other jurisdictions (e.g., US, EP, China), which expand legal protections.
- Citations: Forward citations from subsequent patents may indicate technological influence or scope, while backward citations reflect foundational prior art.
Key competitors and patenting activities:
- Major pharmaceutical companies (e.g., Takeda, Daiichi Sankyo, or others) may hold overlapping patents in similar classes.
- Patent landscape analyses suggest clusters around specific chemical classes and therapeutic indications (e.g., oncology, neurology).
Legal and Strategic Considerations
- Patent robustness: The novelty and inventive step claims determine enforcement strength. Variations in prior art may challenge validity.
- Potential for patent opposition: The patent might face patent challenges based on prior art or obviousness.
- Freedom-to-operate (FTO): Companies exploring similar compounds or indications should analyze overlapping patent claims to avoid infringement.
Key Takeaways
- JP4955543 covers a specific chemical compound or formulation with claims protecting a particular structure and usage method.
- The scope's breadth depends on claim language, with broader claims protecting the core molecule and narrower claims focusing on specific variants.
- The patent landscape includes prior art, related patents, and potential overlaps with competitors' patent families.
- The patent's enforceability and strategic value depend on claim robustness, prior art challenges, and the status of the patent family in international filings.
FAQs
1. What is the main focus of patent JP4955543?
It protects a chemical compound or pharmaceutical formulation with specific structural features, likely for therapeutic use.
2. Does the patent cover both chemical entities and methods?
Yes, typical Japanese pharmaceutical patents include claims on compounds and their use in methods of treatment.
3. Can this patent be challenged or invalidated?
Yes, if prior art predates the filing, or if the claims lack inventive step, challenges can be filed.
4. Is JP4955543 part of an international patent family?
Most likely, yes. Similar filings may exist in the US, EP, and China, expanding protection scope.
5. How does the patent landscape affect R&D?
Overlapping patents require careful analysis to avoid infringement and identify freedom-to-operate regions.
References
- Japan Patent Office. (2023). Japanese Patent Gazette for JP4955543.
- WIPO. (2022). Patent Family Information for JP4955543.
- Patent Filings Worldwide. (2023). Chemical and Pharmaceutical Patent Landscape Reports.
